ADRX peer analysis
ADARx Pharmaceuticals (ADRX) against its competitors: price, today's move, 1-year return and market value side by side.
ADRX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARCT Arcturus | $8.45 | -9.24% | -2.54% | $243.55M |
| BNTC Benitec Biopharma | $9.12 | -3.70% | -31.22% | $318.19M |
| MGTX MeiraGTx | $8.78 | -9.35% | -1.40% | $842.78M |
| PRME Prime Medicine | $3.97 | -7.67% | 1.28% | $720.07M |
| PRQR ProQR Therapeutics | $1.35 | 7.14% | -37.50% | $190.51M |
| RNA Atrium Therapeutics | $7.56 | -5.03% | -89.18% | $129.32M |
| RNAZ TransCode Therapeutics | $1.40 | 3.70% | -84.93% | $1.48M |
| SLN Silence Therapeutics | $19.80 | 0.15% | 194.64% | $935.23M |
| STOK Stoke Therapeutics | $26.19 | -5.66% | 4.30% | $1.71B |
| WVE Wave Life Sciences | $3.15 | -7.75% | -56.54% | $622.26M |
| ADRX ADARx Pharmaceuticals | $14.96 | 12.48% | – | $1.66B |
- ADRX's peers: ARCT (Arcturus), BNTC (Benitec Biopharma), MGTX (MeiraGTx), PRME (Prime Medicine), PRQR (ProQR Therapeutics), RNA (Atrium Therapeutics), RNAZ (TransCode Therapeutics), SLN (Silence Therapeutics).
Updated 2026-11-13 04:50 UTC